The University of New Mexico Cancer Research & Treatment Center is pleased to announce the appointment of Robert Hromas, M.D., a nationally recognized expert in leukemia, lymphoma and myeloma, as associate director for clinical research.

 

Dr. Hromas also has joined the UNM School of Medicine as a professor of medicine and chief of the Hematology/Oncology Division. Before coming to New Mexico, Dr. Hromas was deputy director of the Indiana University Cancer Center and a professor of medicine, genetics and biochemistry at Indiana University Medical Center in Indianapolis.

 

After receiving his bachelor's degree and graduating Magna Cum Laude from Wheaton College, Dr. Hromas earned a master's degree in immunology from Oral Roberts University and graduated first in his class. He received his M.D. from the University of Texas Medical School at Houston, where he was awarded the Outstanding Internal Medicine Student Award.

 

Dr. Hromas did further training at the University of Iowa, the University of Washington and the Fred Hutchinson Cancer Research Center in Seattle.

 

Among the numerous honors Dr. Hromas has received for teaching are the Indiana University Board of Trustees Outstanding Teacher Award and the Indiana Humanism in Medical Education Award. His medical research awards include the Stohlman Scholar Award from the Leukemia and Lymphoma Society and election to the American Society of Clinical Investigation, an honor society of physician investigators. He currently serves as chair of the American Cancer Society's Leukemia and Immunology Review Group.     

 

Dr. Hromas also was selected the graduation speaker for this year's medical school class at Indiana University.

 

"I have always loved New Mexico the mountains, the sky and the people," Dr. Hromas said. "I hope I can be a resource to New Mexicans who have cancer.

 

"I chose New Mexico because this is the best place to build something special, something we all can be proud of," Hromas continued. "The University of New Mexico is poised to become the national leader in many areas of cancer diagnosis, prognosis, and prevention." 

 

Cheryl Willman, M.D., director of the University of New Mexico Cancer Research and Treatment Center, said the center is very fortunate to have Dr. Hromas.

 

"His keen insight into the complexities of leukemia and lymphoma will help us achieve our goal of becoming a National Cancer Institute (NCI) Comprehensive Cancer Center," Willman said. The NCI funds and promotes most of the cancer research in the U.S.

 

"Designation will allow us to bring the very latest therapies to our patients," Willman said.

 

Founded in 1972, the UNM Cancer Research & Treatment Center is the only academic health care facility that is dedicated to both cancer research and patient care.


Contact: Lynn Melton, 272-3322